Contactin 1: A potential therapeutic target and biomarker in gastric cancer

World Journal of Gastroenterology

Volumn 21, Issue 33, 2015, Pages 9707-9716

  Chen, De Hu ^a   Yu, Ji Wei ^a   Jiang, Bo Jian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cancer neoplasms; Contactin 1; Metastasis; Molecular target; Stomach

Indexed keywords

CONTACTIN 1; PHOSPHOPROTEIN PHOSPHATASE; RAMUCIRUMAB; TRASTUZUMAB; TUMOR MARKER; UVOMORULIN; VASCULOTROPIN C; ANTINEOPLASTIC AGENT; CNTN1 PROTEIN, HUMAN;

ARTICLE; AUTISM; BIOCHEMISTRY; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CANCER PREVENTION; CANCER PROGNOSIS; CANCER THERAPY; CIRCULATING TUMOR CELL; CLINICAL EFFECTIVENESS; DISTANT METASTASIS; DRUG TARGETING; ENZYME MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMAN; MOLECULAR BIOLOGY; MOLECULARLY TARGETED THERAPY; NEUROTRANSMITTER RELEASE; PROTEIN EXPRESSION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR INVASION; TUMOR RECURRENCE; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE COURSE; DRUG EFFECTS; METABOLISM; METASTASIS; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; STOMACH NEOPLASMS;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOMARKERS, TUMOR; CONTACTIN 1; DISEASE PROGRESSION; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84941695294     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i33.9707     Document Type: Article

References (91)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359-E386 [PMID: 25220842 DOI: 10.1002/ijc.29210]
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-2917 [PMID: 21351269 DOI: 10.1002/ijc.25516]
4. Kaltenbach T, Sano Y, Friedland S, Soetikno R. American Gastroenterological Association (AGA) Institute technology assessment on image-enhanced endoscopy. Gastroenterology 2008; 134: 327-340 [PMID: 18061178 DOI: 10.1053/j.gastro.2007.10.062]
5. Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S. Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year followup in Japan. Int J Cancer 2006; 118: 2315-2321 [PMID: 16331632 DOI: 10.1002/ijc.21664]
6. Tkachenko MA, Zhannat NZ, Erman LV, Blashenkova EL, Isachenko SV, Isachenko OB, Graham DY, Malaty HM. Dramatic changes in the prevalence of Helicobacter pylori infection during childhood: a 10-year follow-up study in Russia. J Pediatr Gastroenterol Nutr 2007; 45: 428-432 [PMID: 18030208 DOI: 10.1097/MPG.0b013e318064589f]
7. Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, Malvezzi M, La Vecchia C. Recent patterns in gastric cancer: a global overview. Int J Cancer 2009; 125: 666-673 [PMID: 19382179 DOI: 10.1002/ijc.24290]
8. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ; American Cancer Society. Cancer statistics, 2004. CA Cancer J Clin 2004; 54: 8-29 [PMID: 14974761]
9. Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol 2009; 71: 127-164 [PMID: 19230702 DOI: 10.1016/j.critrevonc.2009.01.004]
10. Fang XY, Pan HF, Leng RX, Ye DQ. Long noncoding RNAs: novel insights into gastric cancer. Cancer Lett 2015; 356: 357-366 [PMID: 25444905 DOI: 10.1016/j.canlet.2014.11.005]
11. Guo X, Xia J, Yan J. Promoter methylated microRNAs: potential therapeutic targets in gastric cancer. Mol Med Rep 2015; 11: 759-765 [PMID: 25351138 DOI: 10.3892/mmr.2014.2780]
12. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi K, Fujiwara H, Okamoto K, Otsuji E. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010; 102: 1174-1179 [PMID: 20234369 DOI: 10.1038/sj.bjc.6605608]
13. Matsukawa Y, Semba S, Kato H, Ito A, Yanagihara K, Yokozaki H. Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer. Cancer Sci 2006; 97: 484-491 [PMID: 16734726 DOI: 10.1111/j.1349-7006.2006.00203.x]
14. Zhao ZS, Wang YY, Chu YQ, Ye ZY, Tao HQ. SPARC is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res 2010; 16: 260-268 [PMID: 20028745 DOI: 10.1158/1078-0432.CCR-09-1247]
15. Hou F, Yuan W, Huang J, Qian L, Chen Z, Ge J, Wu S, Chen J, Wang J, Chen Z. Overexpression of EphA2 correlates with epithelial-mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients. Med Oncol 2012; 29: 2691-2700 [PMID: 22189617 DOI: 10.1007/s12032-011-0127-2]
16. Huang J, Xiao D, Li G, Ma J, Chen P, Yuan W, Hou F, Ge J, Zhong M, Tang Y, Xia X, Chen Z. EphA2 promotes epithelialmesenchymal transition through the Wnt/?-catenin pathway in gastric cancer cells. Oncogene 2014; 33: 2737-2747 [PMID: 23752181 DOI: 10.1038/onc.2013.238]
17. Su JL, Yang CY, Shih JY, Wei LH, Hsieh CY, Jeng YM, Wang MY, Yang PC, Kuo ML. Knockdown of contactin-1 expression suppresses invasion and metastasis of lung adenocarcinoma. Cancer Res 2006; 66: 2553-2561 [PMID: 16510572 DOI: 10.1158/0008-5472.CAN-05-2645]
18. Yu JW, Wu SH, Lu RQ, Wu JG, Ni XC, Zhou GC, Jiang HG, Zheng LH, Li XQ, Du GY, Jiang BJ. Expression and significances of contactin-1 in human gastric cancer. Gastroenterol Res Pract 2013; 2013: 210205 [PMID: 23606831 DOI: 10.1155/2013/210205]
19. Bizzoca A, Corsi P, Gennarini G. The mouse F3/contactin glycoprotein: structural features, functional properties and developmental significance of its regulated expression. Cell Adh Migr 2009; 3: 53-63 [PMID: 19372728 DOI: 10.4161/cam.3.1.7462]
20. Bouyain S, Watkins DJ. The protein tyrosine phosphatases PTPRZ and PTPRG bind to distinct members of the contactin family of neural recognition molecules. Proc Natl Acad Sci USA 2010; 107: 2443-2448 [PMID: 20133774 DOI: 10.1073/pnas.0911235107]
21. Shimoda Y, Watanabe K. Contactins: emerging key roles in the development and function of the nervous system. Cell Adh Migr 2009; 3: 64-70 [PMID: 19262165 DOI: 10.4161/cam.3.1.7764]
22. Berglund EO, Ranscht B. Molecular cloning and in situ localization of the human contactin gene (CNTN1) on chromosome 12q11-q12. Genomics 1994; 21: 571-582 [PMID: 7959734 DOI: 10.1006/geno.1994.1316]
23. Bizzoca A, Corsi P, Polizzi A, Pinto MF, Xenaki D, Furley AJ, Gennarini G. F3/Contactin acts as a modulator of neurogenesis during cerebral cortex development. Dev Biol 2012; 365: 133-151 [PMID: 22360968 DOI: 10.1016/j.ydbio.2012.02.011]
24. Bizzoca A, Virgintino D, Lorusso L, Buttiglione M, Yoshida L, Polizzi A, Tattoli M, Cagiano R, Rossi F, Kozlov S, Furley A, Gennarini G. Transgenic mice expressing F3/contactin from the TAG-1 promoter exhibit developmentally regulated changes in the differentiation of cerebellar neurons. Development 2003; 130: 29-43 [PMID: 12441289 DOI: 10.1242/dev.00183]
25. Çolako?lu G, Bergstrom-Tyrberg U, Berglund EO, Ranscht B. Contactin-1 regulates myelination and nodal/paranodal domain organization in the central nervous system. Proc Natl Acad Sci USA 2014; 111: E394-E403 [PMID: 24385581 DOI: 10.1073/pnas.1313769110]
26. Dityatev A, Bukalo O, Schachner M. Modulation of synaptic transmission and plasticity by cell adhesion and repulsion molecules. Neuron Glia Biol 2008; 4: 197-209 [PMID: 19674506 DOI: 10.1017/S1740925X09990111]
27. Hu QD, Ang BT, Karsak M, Hu WP, Cui XY, Duka T, Takeda Y, Chia W, Sankar N, Ng YK, Ling EA, Maciag T, Small D, Trifonova R, Kopan R, Okano H, Nakafuku M, Chiba S, Hirai H, Aster JC, Schachner M, Pallen CJ, Watanabe K, Xiao ZC. F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation. Cell 2003; 115: 163-175 [PMID: 14567914 DOI: 10.1016/S0092-8674(03)00810-9]
28. Peles E, Nativ M, Campbell PL, Sakurai T, Martinez R, Lev S, Clary DO, Schilling J, Barnea G, Plowman GD, Grumet M, Schlessinger J. The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin. Cell 1995; 82: 251-260 [PMID: 7628014 DOI: 10.1016/0092-8674(95)90312-7]
29. Sakurai T, Lustig M, Nativ M, Hemperly JJ, Schlessinger J, Peles E, Grumet M. Induction of neurite outgrowth through contactin and Nr-CAM by extracellular regions of glial receptor tyrosine phosphatase beta. J Cell Biol 1997; 136: 907-918 [PMID: 9049255 DOI: 10.1083/jcb.136.4.907]
30. Parent AS, Mungenast AE, Lomniczi A, Sandau US, Peles E, Bosch MA, Rønnekleiv OK, Ojeda SR. A contactin-receptor-like protein tyrosine phosphatase beta complex mediates adhesive communication between astroglial cells and gonadotrophinreleasing hormone neurones. J Neuroendocrinol 2007; 19: 847-859 [PMID: 17927663 DOI: 10.1111/j.1365-2826.2007.01597.x]
31. Lamprianou S, Chatzopoulou E, Thomas JL, Bouyain S, Harroch S. A complex between contactin-1 and the protein tyrosine phosphatase PTPRZ controls the development of oligodendrocyte precursor cells. Proc Natl Acad Sci USA 2011; 108: 17498-17503 [PMID: 21969550 DOI: 10.1073/pnas.1108774108]
32. Zeng L, D'Alessandri L, Kalousek MB, Vaughan L, Pallen CJ. Protein tyrosine phosphatase alpha (PTPalpha) and contactin form a novel neuronal receptor complex linked to the intracellular tyrosine kinase fyn. J Cell Biol 1999; 147: 707-714 [PMID: 10562275 DOI: 10.1083/jcb.147.4.707]
33. Umemori H, Sato S, Yagi T, Aizawa S, Yamamoto T. Initial events of myelination involve Fyn tyrosine kinase signalling. Nature 1994; 367: 572-576 [PMID: 7509042 DOI: 10.1038/367572a0]
34. Shimazaki K, Hosoya H, Takeda Y, Kobayashi S, Watanabe K. Age-related decline of F3/contactin in rat hippocampus. Neurosci Lett 1998; 245: 117-120 [PMID: 9605499 DOI: 10.1016/S0304-3940(98)00179-7]
35. Hosoya H, Shimazaki K, Kobayashi S, Takahashi H, Shirasawa T, Takenawa T, Watanabe K. Developmental expression of the neural adhesion molecule F3 in the rat brain. Neurosci Lett 1995; 186: 83-86 [PMID: 7777204]
36. Puzzo D, Bizzoca A, Privitera L, Furnari D, Giunta S, Girolamo F, Pinto M, Gennarini G, Palmeri A. F3/Contactin promotes hippocampal neurogenesis, synaptic plasticity, and memory in adult mice. Hippocampus 2013; 23: 1367-1382 [PMID: 23939883 DOI: 10.1002/hipo.22186]
37. Milanese C, Fiumara F, Bizzoca A, Giachello C, Leitinger G, Gennarini G, Montarolo PG, Ghirardi M. F3/contactin-related proteins in Helix pomatia nervous tissue (HCRPs): distribution and function in neurite growth and neurotransmitter release. J Neurosci Res 2008; 86: 821-831 [PMID: 17941055 DOI: 10.1002/jnr.21539]
38. Burbach JP, van der Zwaag B. Contact in the genetics of autism and schizophrenia. Trends Neurosci 2009; 32: 69-72 [PMID: 19135727 DOI: 10.1016/j.tins.2008.11.002]
39. Liu P, Chen S, Wu W, Liu B, Shen W, Wang F, He X, Zhang S. Contactin-1 (CNTN-1) overexpression is correlated with advanced clinical stage and lymph node metastasis in oesophageal squamous cell carcinomas. Jpn J Clin Oncol 2012; 42: 612-618 [PMID: 22581910 DOI: 10.1093/jjco/hys066]
40. Qin XJ, Dai DJ, Gao ZG, Huan JL, Zhu L. Effect of lentivirusmediated shRNA targeting VEGFR-3 on proliferation, apoptosis and invasion of gastric cancer cells. Int J Mol Med 2011; 28: 761-768 [PMID: 21805024 DOI: 10.3892/ijmm.2011.758]
41. Su JL, Yang PC, Shih JY, Yang CY, Wei LH, Hsieh CY, Chou CH, Jeng YM, Wang MY, Chang KJ, Hung MC, Kuo ML. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 2006; 9: 209-223 [PMID: 16530705 DOI: 10.1016/j.ccr.2006.02.018]
42. Wu HM, Cao W, Ye D, Ren GX, Wu YN, Guo W. Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma. Mol Med Rep 2012; 6: 265-270 [PMID: 22580838 DOI: 10.3892/mmr.2012.910]
43. Tsai KH, Hsien HH, Chen LM, Ting WJ, Yang YS, Kuo CH, Tsai CH, Tsai FJ, Tsai HJ, Huang CY. Rhubarb inhibits hepatocellular carcinoma cell metastasis via GSK-3-? activation to enhance protein degradation and attenuate nuclear translocation of ?-catenin. Food Chem 2013; 138: 278-285 [PMID: 23265488 DOI: 10.1016/j.foodchem.2012.10.038]
44. Vinarskaja A, Yamanaka M, Ingenwerth M, Schulz WA. DNA Methylation and the HOXC6 Paradox in Prostate Cancer. Cancers (Basel) 2011; 3: 3714-3725 [PMID: 24213107 DOI: 10.3390/cancers3043714]
45. Prag S, Lepekhin EA, Kolkova K, Hartmann-Petersen R, Kawa A, Walmod PS, Belman V, Gallagher HC, Berezin V, Bock E, Pedersen N. NCAM regulates cell motility. J Cell Sci 2002; 115: 283-292 [PMID: 11839780]
46. Lehembre F, Yilmaz M, Wicki A, Schomber T, Strittmatter K, Ziegler D, Kren A, Went P, Derksen PW, Berns A, Jonkers J, Christofori G. NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO J 2008; 27: 2603-2615 [PMID: 18772882 DOI: 10.1038/emboj.2008.178]
47. Hung YH, Hung WC. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) enhances invasiveness of lung cancer cells by up-regulating contactin-1 via the alpha7 nicotinic acetylcholine receptor/ERK signaling pathway. Chem Biol Interact 2009; 179: 154-159 [PMID: 19027725 DOI: 10.1016/j.cbi.2008.10.042]
48. Zang ZJ, Cutcutache I, Poon SL, Zhang SL, McPherson JR, Tao J, Rajasegaran V, Heng HL, Deng N, Gan A, Lim KH, Ong CK, Huang D, Chin SY, Tan IB, Ng CC, Yu W, Wu Y, Lee M, Wu J, Poh D, Wan WK, Rha SY, So J, Salto-Tellez M, Yeoh KG, Wong WK, Zhu YJ, Futreal PA, Pang B, Ruan Y, Hillmer AM, Bertrand D, Nagarajan N, Rozen S, Teh BT, Tan P. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat Genet 2012; 44: 570-574 [PMID: 22484628 DOI: 10.1038/ng.2246]
49. Chen H, Yu JW, Wu JG, Wang SL, Jiang BJ. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells. J Cancer Res Clin Oncol 2015; Epub ahead of print [PMID: 25952582]
50. Liu P, Zhou J, Zhu H, Xie L, Wang F, Liu B, Shen W, Ye W, Xiang B, Zhu X, Shi R, Zhang S. VEGF-C promotes the development of esophageal cancer via regulating CNTN-1 expression. Cytokine 2011; 55: 8-17 [PMID: 21482472 DOI: 10.1016/j.cyto.2011.03.008]
51. Mauerer A, Roesch A, Hafner C, Stempfl T, Wild P, Meyer S, Landthaler M, Vogt T. Identification of new genes associated with melanoma. Exp Dermatol 2011; 20: 502-507 [PMID: 21410771 DOI: 10.1111/j.1600-0625.2011.01254.x]
52. Mhawech-Fauceglia P, Wang D, Kesterson J, Clark K, Monhollen L, Odunsi K, Lele S, Liu S. Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma. PLoS One 2010; 5: e15415 [PMID: 21079744 DOI: 10.1371/journal.pone.0015415.s001]
53. Eckerich C, Zapf S, Ulbricht U, Müller S, Fillbrandt R, Westphal M, Lamszus K. Contactin is expressed in human astrocytic gliomas and mediates repulsive effects. Glia 2006; 53: 1-12 [PMID: 16078236 DOI: 10.1002/glia.20254]
54. Nord H, Hartmann C, Andersson R, Menzel U, Pfeifer S, Piotrowski A, Bogdan A, Kloc W, Sandgren J, Olofsson T, Hesselager G, Blomquist E, Komorowski J, von Deimling A, Bruder CE, Dumanski JP, Díaz de Ståhl T. Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array. Neuro Oncol 2009; 11: 803-818 [PMID: 19304958 DOI: 10.1215/15228517-2009-013]
55. Colussi D, Brandi G, Bazzoli F, Ricciardiello L. Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci 2013; 14: 16365-16385 [PMID: 23965959 DOI: 10.3390/ijms140816365]
56. Bardhan K, Liu K. Epigenetics and colorectal cancer pathogenesis. Cancers (Basel) 2013; 5: 676-713 [PMID: 24216997 DOI: 10.3390/cancers5020676]
57. Zoratto F, Rossi L, Verrico M, Papa A, Basso E, Zullo A, Tomao L, Romiti A, Lo Russo G, Tomao S. Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis. Tumour Biol 2014; 35: 6195-6206 [PMID: 25051912 DOI: 10.1007/s13277-014-1845-9]
58. Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt JA, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol 2013; 26: 465-484 [PMID: 23307060 DOI: 10.1038/modpathol.2012.214]
59. Huang J, Asawa T, Takato T, Sakai R. Cooperative roles of Fyn and cortactin in cell migration of metastatic murine melanoma. J Biol Chem 2003; 278: 48367-48376 [PMID: 13129922 DOI: 10.1074/jbc.M308213200]
60. Cooper JA. The role of actin polymerization in cell motility. Annu Rev Physiol 1991; 53: 585-605 [PMID: 2042972 DOI: 10.1146/annurev.ph.53.030191.003101]
61. Pinnix CC, Lee JT, Liu ZJ, McDaid R, Balint K, Beverly LJ, Brafford PA, Xiao M, Himes B, Zabierowski SE, Yashiro-Ohtani Y, Nathanson KL, Bengston A, Pollock PM, Weeraratna AT, Nickoloff BJ, Pear WS, Capobianco AJ, Herlyn M. Active Notch1 confers a transformed phenotype to primary human melanocytes. Cancer Res 2009; 69: 5312-5320 [PMID: 19549918 DOI: 10.1158/0008-5472. CAN-08-3767]
62. Peng Z, Wang CX, Fang EH, Wang GB, Tong Q. Role of epithelial-mesenchymal transition in gastric cancer initiation and progression. World J Gastroenterol 2014; 20: 5403-5410 [PMID: 24833870 DOI: 10.3748/wjg.v20.i18.5403]
63. Yan J, Wong N, Hung C, Chen WX, Tang D. Contactin-1 reduces E-cadherin expression via activating AKT in lung cancer. PLoS One 2013; 8: e65463 [PMID: 23724143 DOI: 10.1371/journal. pone.0065463]
64. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008; 68: 3645-3654 [PMID: 18483246 DOI: 10.1158/0008-5472.CAN-07-2938]
65. Boral D, Nie D. Cancer stem cells and niche mircoenvironments. Front Biosci (Elite Ed) 2012; 4: 2502-2514 [PMID: 22652656]
66. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-648 [PMID: 7509044 DOI: 10.1038/367645a0]
67. Yu Z, Pestell TG, Lisanti MP, Pestell RG. Cancer stem cells. Int J Biochem Cell Biol 2012; 44: 2144-2151 [PMID: 22981632 DOI: 10.1016/j.biocel.2012.08.022]
68. Ailles LE, Weissman IL. Cancer stem cells in solid tumors. Curr Opin Biotechnol 2007; 18: 460-466 [PMID: 18023337 DOI: 10.1016/j.copbio.2007.10.007]
69. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, Gordon SA, Shimada Y, Wang TC. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009; 27: 1006-1020 [PMID: 19415765 DOI: 10.1002/stem.30]
70. Zhang C, Li C, He F, Cai Y, Yang H. Identification of CD44+CD24+ gastric cancer stem cells. J Cancer Res Clin Oncol 2011; 137: 1679-1686 [PMID: 21882047 DOI: 10.1007/s00432-011-1038-5]
71. Barcellos-Hoff MH, Lyden D, Wang TC. The evolution of the cancer niche during multistage carcinogenesis. Nat Rev Cancer 2013; 13: 511-518 [PMID: 23760023 DOI: 10.1038/nrc3536]
72. Bendas G, Borsig L. Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins. Int J Cell Biol 2012; 2012: 676731 [PMID: 22505933 DOI: 10.1155/2012/676731]
73. Gradilone A, Raimondi C, Nicolazzo C, Petracca A, Gandini O, Vincenzi B, Naso G, Aglianò AM, Cortesi E, Gazzaniga P. Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal. J Cell Mol Med 2011; 15: 1066-1070 [PMID: 21352474 DOI: 10.1111/j.1582-4934.2011.01285.x]
74. Floor S, van Staveren WC, Larsimont D, Dumont JE, Maenhaut C. Cancer cells in epithelial-to-mesenchymal transition and tumorpropagating-cancer stem cells: distinct, overlapping or same populations. Oncogene 2011; 30: 4609-4621 [PMID: 21643013 DOI: 10.1038/onc.2011.184]
75. Scheel C, Weinberg RA. Phenotypic plasticity and epithelialmesenchymal transitions in cancer and normal stem cells? Int J Cancer 2011; 129: 2310-2314 [PMID: 21792896 DOI: 10.1002/ijc.26311]
76. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008; 14: 818-829 [PMID: 18539112 DOI: 10.1016/j.devcel.2008.05.009]
77. Tinhofer I, Saki M, Niehr F, Keilholz U, Budach V. Cancer stem cell characteristics of circulating tumor cells. Int J Radiat Biol 2014; 90: 622-627 [PMID: 24460132 DOI: 10.3109/09553002.201 4.886798]
78. Ksikiewicz M, Markiewicz A, Zaczek AJ. Epithelialmesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells. Pathobiology 2012; 79: 195-208 [PMID: 22488297 DOI: 10.1159/000337106]
79. Illert B, Fein M, Otto C, Cording F, Stehle D, Thiede A, Timmermann W. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis. Scand J Gastroenterol 2005; 40: 843-849 [PMID: 16109661 DOI: 10.1080/00365520510015557]
80. Zhang Y, Li J, Cao L, Xu W, Yin Z. Circulating tumor cells in hepatocellular carcinoma: detection techniques, clinical implications, and future perspectives. Semin Oncol 2012; 39: 449-460 [PMID: 22846862 DOI: 10.1053/j.seminoncol.2012.05.012]
81. Li M, Zhang B, Zhang Z, Liu X, Qi X, Zhao J, Jiang Y, Zhai H, Ji Y, Luo D. Stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer. Biomed Res Int 2014; 2014: 981261 [PMID: 24963492 DOI: 10.1155/2014/981261]
82. Yu JW, Wu JG, Tajima Y, Li XQ, Du GY, Zheng LH, Zhang B, Ni XC, Jiang BJ. Study on lymph node metastasis correlated to lymphangiogenesis, lymphatic vessel invasion, and lymph node micrometastasis in gastric cancer. J Surg Res 2011; 168: 188-196 [PMID: 20189585 DOI: 10.1016/j.jss.2009.10.030]
83. Ezoe Y, Muto M, Uedo N, Doyama H, Yao K, Oda I, Kaneko K, Kawahara Y, Yokoi C, Sugiura Y, Ishikawa H, Takeuchi Y, Kaneko Y, Saito Y. Magnifying narrowband imaging is more accurate than conventional white-light imaging in diagnosis of gastric mucosal cancer. Gastroenterology 2011; 141: 2017-2025.e3 [PMID: 21856268 DOI: 10.1053/j.gastro.2011.08.007]
84. Nagahama T, Yao K, Maki S, Yasaka M, Takaki Y, Matsui T, Tanabe H, Iwashita A, Ota A. Usefulness of magnifying endoscopy with narrow-band imaging for determining the horizontal extent of early gastric cancer when there is an unclear margin by chromoendoscopy (with video). Gastrointest Endosc 2011; 74: 1259-1267 [PMID: 22136775 DOI: 10.1016/j.gie.2011.09.005]
85. Oka S, Tanaka S, Kaneko I, Mouri R, Hirata M, Kawamura T, Yoshihara M, Chayama K. Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Gastrointest Endosc 2006; 64: 877-883 [PMID: 17140890 DOI: 10.1016/j.gie.2006.03.932]
86. Orditura M, Galizia G, Sforza V, Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J, Savastano B, Mabilia A, Lieto E, Ciardiello F, De Vita F. Treatment of gastric cancer. World J Gastroenterol 2014; 20: 1635-1649 [PMID: 24587643 DOI: 10.3748/wjg.v20.i7.1635]
87. Pasini F, Fraccon AP, DE Manzoni G. The role of chemotherapy in metastatic gastric cancer. Anticancer Res 2011; 31: 3543-3554 [PMID: 21965776]
88. Coratti A, Annecchiarico M, Di Marino M, Gentile E, Coratti F, Giulianotti PC. Robot-assisted gastrectomy for gastric cancer: current status and technical considerations. World J Surg 2013; 37: 2771-2781 [PMID: 23674257 DOI: 10.1007/s00268-013-2100-z]
89. Uyama I, Suda K, Satoh S. Laparoscopic surgery for advanced gastric cancer: current status and future perspectives. J Gastric Cancer 2013; 13: 19-25 [PMID: 23610715 DOI: 10.5230/jgc.2013.13.1.19]
90. Smyth EC, Cunningham D. Targeted therapy for gastric cancer. Curr Treat Options Oncol 2012; 13: 377-389 [PMID: 22552927 DOI: 10.1007/s11864-012-0192-6]
91. Liu XE, Sun XD, Wu JM. Expression and significance of VEGF-C and FLT-4 in gastric cancer. World J Gastroenterol 2004; 10: 352-355 [PMID: 14760756]